Clenoliximab
Source: Wikipedia, the free encyclopedia.
Monoclonal antibody
| Target | CD4 |
|---|---|
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
 N Y (what is this?) (verify) | |
Clenoliximab (
immunomodulator and has been investigated for the treatment of rheumatoid arthritis.[2]
The drug is a Homo sapiens.[1]
References
- ^ a b World Health Organization (1997). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 77" (PDF). WHO Drug Information. 11 (2): 89. Archived from the original (PDF) on June 27, 2004.
- PMID 12509613.
| Intracellular (initiation) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (reception) |
| ||||||||||||||
| Extracellular |
| ||||||||||||||
| Unsorted |
| ||||||||||||||
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
drug article is a stub. You can help Wikipedia by expanding it. |